Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2010
01/14/2010WO2008083312A3 Chemical linkers and cleavable substrates and conjugates thereof
01/14/2010US20100011306 Data-driven layout engine
01/14/2010US20100010234 Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof
01/14/2010US20100010042 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
01/14/2010US20100010033 Bis-carbazole DNA intercalating agents for antitumor therapy
01/14/2010US20100010008 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
01/14/2010US20100010004 Inhibitors of histone deacetylase
01/14/2010US20100010003 Pyrimidine Derivatives And Their Use As Pesticides
01/14/2010US20100009990 Imidazolyl pyrimidine inhibitor compounds
01/14/2010US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
01/14/2010US20100009986 Substituted heteroaryl derivatives
01/14/2010US20100009965 Cyclic malonamides as inhibitors of abeta protein production
01/14/2010US20100009961 Dipeptidyl peptidase-iv inhibitors
01/14/2010US20100008956 Composition and combinations of carboxylic acid losartan in dosage forms
01/14/2010CA2730251A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
01/14/2010CA2730231A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
01/14/2010CA2730116A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
01/14/2010CA2730079A1 Processes for the preparation of crystalline forms of sunitinib malate
01/14/2010CA2730078A1 Nitrogen-containing aromatic heterocyclyl compound
01/14/2010CA2730037A1 Sulfone compounds which modulate the cb2 receptor
01/13/2010EP2142536A1 Aminopyrimidine derivatives as glutaminyl cyclase inhibitors
01/13/2010EP2142535A2 3-imidazolyl-indoles for the treatment of proliferative diseases
01/13/2010EP2142534A2 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
01/13/2010EP2142516A1 Pyrimidine hydrazide compounds as pgds inhibitors
01/13/2010EP2142512A2 Imidazolidine carboxamide derivatives as p2x7 modulators
01/13/2010EP1869018B1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands
01/13/2010EP1753747B1 5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents
01/13/2010EP1451160B1 Pyrazole-amides for use in the treatment of pain
01/13/2010EP1144388B1 Acyl derivatives which treat vla-4 related disorders
01/13/2010CN101627031A Salts of 3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl] -pyrrole-2, 5-di one
01/13/2010CN101624392A Novel F-triazole ring-polyethyleneglycol-2-nitroimidazole compound and preparation method thereof
01/13/2010CN100579977C Method for producing antifungal drug in triazole class
01/13/2010CN100579976C P38 inhibitors and methods of use thereof
01/13/2010CN100579968C Quinazolinone derivatives and their use as CB agonists
01/13/2010CN100579579C Anti-cancer and anti-infectious disease compositions and methods for using same
01/13/2010CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
01/12/2010US7645878 Reacting an aniline derivative with an acylchloride to form an intermeidate, cyclizing the intermediate, replacing hydroxy group with a leaving group (chloride), racting the product with an amino-heterocyclic compound
01/12/2010US7645784 Benzimidazole derivatives
01/12/2010US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
01/12/2010US7645773 Thiazoles as inhibitors of 11β-hydroxysteroid dehydrogenase
01/12/2010US7645761 Indoline derivatives
01/12/2010US7645758 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis
01/12/2010US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/12/2010US7645752 Inhibitors of norepinephrine reuptake; 5-HT2A receptor inhibitors; N,N-dimethyl-N-{2-[3-(phenylsulfonyl)-1H-indol-5-yl]ethyl}amine; 3-(phenylsulfonyl)-7-(2-pyrrolidin-1-ylethyl)-1H-indole;
01/12/2010US7645751 Mandelic acid derivatives and their use as thrombin inhibitors
01/12/2010CA2560489C Pyranone compounds useful to treat retroviral infections
01/12/2010CA2381088C Use of acylsulfonamido-substituted polymethine dyes as fluorescence dyes and/or markers
01/12/2010CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors
01/12/2010CA2192089C Inhibitors of interleukin-1.beta. converting enzyme
01/07/2010WO2010003048A1 Benzimidazoles and related analogs as sirtuin modulators
01/07/2010WO2010003025A1 Bicyclic heterocycles as mek kinase inhibitors
01/07/2010WO2010002777A2 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
01/07/2010WO2010002655A2 Compounds and compositions as kinase inhibitors
01/07/2010WO2010001946A1 Triazole derivative or salt thereof
01/07/2010WO2010001933A1 Histone modification inhibitor specific to target gene
01/07/2010WO2010001869A1 Tetra-substituted benzene compound and use thereof
01/07/2010WO2010001167A2 Novel process
01/07/2010WO2010001042A2 Cosmetic composition, compound, and cosmetic treatment method
01/07/2010WO2010001041A2 Cosmetic composition, cosmetic treatment method, and compound
01/07/2010WO2010000633A1 Novel phenylpyrazinones as kinase inhibitors
01/07/2010WO2009140448A8 Tetrahydrocyclopenta[b]indole androgen receptor modulators
01/07/2010WO2009131687A3 Inhibitors of protein kinases
01/07/2010WO2009121063A3 Chemokine receptor modulators
01/07/2010WO2009117421A3 Heterocyclic modulators of gpr119 for treatment of disease
01/07/2010WO2009103432A3 Covalently binding imaging probes
01/07/2010WO2009095773A8 Novel heterocycles
01/07/2010WO2009007536A8 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
01/07/2010WO2009000533A8 Novel herbicides
01/07/2010US20100004308 Benzofuran-3-yl(indol-3-yl) Maleimides as Potent GSK3 Inhibitors
01/07/2010US20100004265 1,2,3-triazole derivatives as sigma receptor inhibitors
01/07/2010US20100004264 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/07/2010US20100004263 Mtp inhibiting aryl piperidines or peperazines substituted with5-membered heterocycles
01/07/2010US20100004254 Therapeutic agents useful for treating pain
01/07/2010US20100004245 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
01/07/2010US20100004231 Inhibitors of burton's tyrosine kinase
01/07/2010US20100004227 Compositions and methods relating to novel compounds and targets thereof
01/07/2010US20100004224 1,2,4-triazole derivatives as sigma receptor inhibitors
01/07/2010US20100004159 Substituted imidazolone derivatives, preparations and uses
01/07/2010US20100003612 Isoindoline pigments
01/07/2010US20100003246 Novel heterocyclic compounds and uses therof
01/07/2010CA2729703A1 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
01/07/2010CA2729495A1 Pyrimidine derivatives as kinase inhibitors
01/07/2010CA2729408A1 Triazole derivative or salt thereof
01/07/2010CA2729253A1 Novel process
01/07/2010CA2729128A1 Benzimidazoles and related analogs as sirtuin modulators
01/07/2010CA2728683A1 Novel phenylpyrazinones as kinase inhibitors
01/07/2010CA2727250A1 Bicyclic heterocycles as mek kinase inhibitors
01/06/2010EP2141152A1 Compound for organic electroluminescent device and organic electroluminescent device
01/06/2010EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods
01/06/2010EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods
01/06/2010EP2139879A1 Quinoline derivatives for the treatment of inflammatory diseases
01/06/2010EP2139857A1 Sub-type selective azabicycloalkane derivatives
01/06/2010EP2139856A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one-compounds
01/06/2010EP2139331A1 Compositions and methods relating to novel compounds and targets thereof
01/06/2010EP2038275B1 Novel pyridazine compound and use thereof
01/06/2010EP1735278B1 Histamine h3 receptor agents, preparation and therapeutic uses
01/06/2010EP1635835B1 2-aminopyrimidine derivatives as raf kinase inhibitors
01/06/2010EP1562911B1 Compositions useful as inhibitors of jak and other protein kinases
01/06/2010EP1513831B1 Novel compounds, their use and preparation
01/06/2010EP0934281B1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators